Life Sciences

Psychiatric journal to disclose industry ties

Pharma Compliance Alert, September 10, 2008

The editor in chief of Psychiatric Times announced the journal will disclose potential conflicts of interest in its editorial board to “help ensure fair and accurate reporting,” according to a journal editorial.

All members of the journal’s editorial board will be asked to submit a detailed disclosure form, including:

  • Membership on a pharmaceutical company speaker’s bureau
  • Major stockholdings in a drug or medical device company
  • Receipt of funding for research, or of frequent honoraria, from such companies

The Senate has been investigating ties between prominent academic psychiatrists, universities, and pharmaceutical companies. The pharmaceutical industry’s largest trade association, PhRMA, issued new guidance in part to make interactions between pharmaceutical companies and healthcare providers more transparent.

Comments

0 comments on “Psychiatric journal to disclose industry ties

 

Most Popular

Related Articles